arXiv

HR-VILAGE-3K3M: A Human Respiratory Viral Immunization Longitudinal Gene Expression Dataset for Systems Immunity

Title: HR-VILAGE-3K3M: A Comprehensive Human Respiratory Viral Immunization Longitudinal Gene Expression Dataset for Systems Immunity

Abstract:

While respiratory viral infections represent a significant global health challenge, the specific cellular immune pathways responsible for both protective immunity and disease pathology are not yet fully understood. Although natural infection studies often suffer from the absence of pre-exposure baselines and inconsistent timing in sample collection, controlled inoculation and vaccination trials yield highly structured longitudinal transcriptomic data. Despite this, such datasets are currently fragmented across various repositories and subjected to disparate processing methods, which impedes integrative research and AI-driven analysis.

To overcome these obstacles, we have introduced the Human Respiratory Viral Immunization LonginAl Gene Expression (HR-VILAGE-3K3M) repository. This AI-optimized resource consolidates bulk and single-cell transcriptomic profiles derived from 3,178 participants drawn from 66 distinct studies. The collection encompasses data from vaccination, inoculation, and mixed exposure scenarios, utilizing samples obtained from blood and nasal swabs sourced from public databases such as GEO, ImmPort, and ArrayExpress.

Our curation process involved harmonizing subject-level metadata, standardizing outcome metrics, and implementing a unified preprocessing pipeline accompanied by stringent quality control measures. Additionally, we present benchmark analyses to demonstrate the dataset’s practical applications. As one of the most extensive longitudinal transcriptomic resources dedicated to human respiratory viral immunization, HR-VILAGE-3K3M facilitates reproducible and scalable investigations, thereby accelerating advancements in vaccine development and antiviral strategies. This resource is instrumental in uncovering novel biomarkers, elucidating immune mechanisms, and driving methodological innovation.


Source: arXiv Generated at: 2026-06-02 00:00:00 UTC

Related Articles

Law’s Billable Hour Is Being Shredded by AI
Bloomberg

Law’s Billable Hour Is Being Shredded by AI

AI is dismantling the billable hour by automating routine legal tasks. This technological shift threatens the traditiona...

Iran War: Trump Tries to Stop Israel’s Lebanon Push | The Opening Trade 6/2/2026
Bloomberg

Iran War: Trump Tries to Stop Israel’s Lebanon Push | The Opening Trade 6/2/2026

SoftBank in Early Talks to Back $800 Million Agile Robots Round
Bloomberg

SoftBank in Early Talks to Back $800 Million Agile Robots Round

SoftBank is in early talks to back Agile Robots’ $800 million funding round. The Japanese tech giant is currently in pre...

Amundi Is Diversifying Risk Via Commodity Currencies, Gold
Bloomberg

Amundi Is Diversifying Risk Via Commodity Currencies, Gold

Amundi diversifies risk by investing in commodity-linked currencies and gold. This strategy hedges against market volati...

Reuters

Marvell Technology surges after Nvidia's Huang calls it 'next trillion-dollar company'

Marvell Technology shares surged after Nvidia CEO Jensen Huang labeled the firm the “next trillion-dollar company.”

Russia Says It Found Foreign Spyware on Top Officials’ Phones
Bloomberg

Russia Says It Found Foreign Spyware on Top Officials’ Phones

Russia’s FSB claims to have discovered foreign spyware on senior officials’ phones. Moscow attributes the intrusion to h...